检索结果 - Yutaka Fujiwara

Refine Results
  1. 1
    EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

    EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib 由 Hideki Kimura, Yutaka Fujiwara, T. Sone, Hideo Kunitoh, Tomohide Tamura, Kazuo Kasahara, Kazuto Nishio

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients

    Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients 由 Yutaka Fujiwara, Naomi Kiyota, Naoko Chayahara, Akiyuki Suzuki, Yoshiko Umeyama, Toru Mukohara, Hironobu Minami

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    High sensitivity detection of <i>epidermal growth factor receptor</i> mutations in the pleural effusion of non‐small cell lung cancer patients

    High sensitivity detection of <i>epidermal growth factor receptor</i> mutations in the pleural effusion of non‐small cell lung cancer patients 由 Hideharu Kimura, Yutaka Fujiwara, Takashi Sone, Hideo Kunitoh, Tomohide Tamura, Kazuo Kasahara, Kazuto Nishio

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Phase I and Pharmacokinetic Study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese Patients with Solid Tumors

    Phase I and Pharmacokinetic Study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese Patients with Solid Tumors 由 Nobuyuki Yamamoto, Yasuhide Yamada, Yutaka Fujiwara, K Yamada, Y. Fujisaka, Toshio Shimizu, Tetsutaro Tamura

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

    Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors 由 Hidenori Mizugaki, Noboru Yamamoto, Haruyasu Murakami, Hirotsugu Kenmotsu, Yutaka Fujiwara, Yoshimasa Ishida, Tomohisa Kawakami, Toshiaki Takahashi

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

    Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer 由 Katsutoshi Sekine, Shintaro Kanda, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Noriko Motoi, Yuichiro Ohe

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort

    Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort 由 Toshihiko Doi, Yutaka Fujiwara, Takafumi Koyama, Masafumi Ikeda, Christoph Helwig, Morihiro Watanabe, Yulia Vugmeyster, Masatoshi Kudo

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

    Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks 由 Yu Kataoka, Toru Mukohara, Hideo Tomioka, Yohei Funakoshi, Naomi Kiyota, Yutaka Fujiwara, Masakazu Yashiro, Kosei Hirakawa, Midori Hirai, Hironobu Minami

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors

    Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors 由 Kazuhiko Yamada, Noboru Yamamoto, Yasuhide Yamada, Hiroshi Nokihara, Yutaka Fujiwara, Taizo Hirata, Fumiaki Koizumi, Kazuto Nishio, Noriyuki Koyama, Tomohide Tamura

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

    Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab 由 Shiro Kimbara, Yutaka Fujiwara, Shintaro Iwama, Ken Ohashi, Aya Kuchiba, Hiroshi Arima, Naoya Yamazaki, Shigehisa Kitano, Noboru Yamamoto, Yuichiro Ohe

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with <scp>anti‐PD</scp>‐1 antibody

    Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with <scp>anti‐PD</scp>‐1 antibody 由 Shuji Murakami, Ryota Shibaki, Yuji Matsumoto, Tatsuya Yoshida, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer

    Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer 由 Yutaka Fujiwara, Takashi Kobayashi, Naoko Chayahara, Yoshinori Imamura, Masanori Toyoda, Naomi Kiyota, Toru Mukohara, Shin Nishiumi, Takeshi Azuma, Masaru Yoshida, Hironobu Minami

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

    Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma 由 Yosuke Tamura, Yutaka Fujiwara, Noboru Yamamoto, Hiroshi Nokihara, Hidehito Horinouchi, Shintaro Kanda, Yasushi Goto, Emi Kubo, Shinsuke Kitahara, Kenjiro Tsuruoka, Koji Tsuta, Yuichiro Ohe

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

    Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 a... 由 Ryota Shibaki, Shuji Murakami, Yuji Matsumoto, Tatsuya Yoshida, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Nobuyuki Yamamoto, Masahiko Kusumoto, Noboru Yamamoto, Yuichiro Ohe

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

    Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study 由 Shunji Takahashi, Yutaka Fujiwara, Kenji Nakano, Toshio Shimizu, Junichi Tomomatsu, Takafumi Koyama, Mariko Ogura, Masaya Tachibana, Yasuyuki Kakurai, Tomonari Yamashita, Sakura Sakajiri, Noboru Yamamoto

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy

    Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy 由 Yuki Katsuya, Hidehito Horinouchi, Tetsuhiko Asao, Shinsuke Kitahara, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Shun‐ichi Watanabe, Koji Tsuta, Yuichiro Ohe

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer

    Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer 由 Hidehito Horinouchi, Noboru Yamamoto, Yutaka Fujiwara, Ikuo Sekine, Hiroshi Nokihara, Kaoru Kubota, Shintaro Kanda, Shigehiro Yagishita, Hiroshi Wakui, Satoru Kitazono, Hidenori Mizugaki, Takuto Tokudome, Tomohide Tamura

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease

    Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease 由 Hirotsugu Kenmotsu, Kiyotaka Yoh, Keita Mori, Akira Ono, Tomohisa Baba, Yutaka Fujiwara, Ou Yamaguchi, Ryo Ko, Hiroaki Okamoto, Nobuyuki Yamamoto, Takashi Ninomiya, Takashi Ogura, Terufumi Kato

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

    First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Soli... 由 Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori, Takafumi Koyama, Jun Sato, Kenji Tamura, Akihiko Shimomura, Hiroki Ikezawa, Maiko Nomoto, Keiji Furuuchi, Ryo Nakajima, Takuma Miura, Noboru Yamamoto

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    PD-L1 expression in neuroendocrine tumors of the lung

    PD-L1 expression in neuroendocrine tumors of the lung 由 Kenjiro Tsuruoka, Hidehito Horinouchi, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Keisuke Asakura, Kazuo Nakagawa, Hiroyuki Sakurai, Shun-ichi Watanabe, Koji Tsuta, Yuichiro Ohe

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: